CD Antigen Cancer Therapy Market Size, Share & Trends Analysis Report By Type of CD Antigen Targeted (CD19, CD20, CD30, CD33, CD38, CD70), By Therapy Type [Monoclonal Antibodies (mAbs), Antibody-Drug Conjugates (ADCs), Chimeric Antigen Receptor (CAR) T-cell Therapy, Bi-specific T-cell Engagers (BiTEs), Radioimmunotherapy, Immunotoxins], By Cancer Type, By End User, By Region, And By Segment Forecasts, 2024-2031

Explore our pricing plans

Single User License

$4456

PDF Report and Excel Datasheet
Delivered in 24-72 hrs. of purchase
Access for one individual only
Analyst support up to 3 Months

Purchase Now

Multi-User License

$7786

PDF Report, Excel Datasheet and Power BI
Delivered in 24-72 hrs. of purchase
Access for 5-6 individuals only
Analyst support up to 3 Months

Purchase Now

Corporate License

$10000

PDF Report, Excel Datasheet and Power BI
Delivered in 24-72 hrs. of purchase
Unlimited access for all employees within the organization
Analyst support up to 6 Months

Purchase Now

Quantitative Data Access

$1200

PowerBI/Excel Pivot Dashboard
Excel Datasheet and Power BI
Delivered in 24-72 hrs. of purchase
Unlimited access for all employees within the organization
Analyst support up to 6 Months

Purchase Now